RxDoctor Payments Data

Dhruvil Pandya, MD

Vascular & Interventional Radiology · Winfield, ILNPI 1477627396

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Medical Device Business Services, Inc. at 37.3% of the total. Reporting peaked in 2021 at $1,525 and has fallen 77.5% since, to $343 in 2024. That places this record below the midpoint for vascular & interventional radiology clinicians in IL, where the typical reported total is $3,270.

$3,564in general payments, 2019–2025

Across 25 payments — averaging $142.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Penumbra, Inc.$900
  • Microvention, Inc.$815
  • Stryker$222
  • Medtronic$210
  • Merck$86
$4,604in research payments, 2019–2025

Across 1 payment — averaging $4603.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$5K

What the payments were for

  • Travel & lodging$1,61745%
  • Food & beverage$1,94755%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.8$1,330
Penumbra, Inc.3$900
Microvention, Inc.6$815
Stryker2$222
Medtronic(2 entities)5$210
Merck1$86

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,564 in reported general payments places this provider in the 50th percentile of 197 vascular & interventional radiology providers in Illinois.

See all vascular & interventional radiology providers in Illinois

Medicare billing

Part B allowed, 2024
$124,300
Medicare patients
286
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$18,772
Atorvastatin Calcium85$928
Levetiracetam19$792
Memantine Hcl14$629
Gabapentin12$466
Rosuvastatin Calcium55$252
ClopidogrelClopidogrel Bisulfate14$178
Lisinopril11$52
Fluoxetine Hcl14$50

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Winfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →